Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

684
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
684
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Prodrugs01:30

Prodrugs

2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.6K
Principles of Drug Action01:24

Principles of Drug Action

5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prediction of drug hypersensitivity by comprehensive modeling of HLA-peptidomes.

Briefings in bioinformatics·2026
Same author

Muscone Promotes PINK1/Parkin-Associated Mitophagy to Suppress NLRP3 Inflammasome Activation: Implications for Endotoxemia Therapy.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Quantitative <sup>1</sup>H NMR in Pharmaceutical and Biomedical Analyses: Methodologies and Applications.

Molecules (Basel, Switzerland)·2026
Same author

A Machine Vision-Guided Microphysiological Platform With Automated Microfluidics Enables Longitudinal Biomarker Monitoring and Emulation of Translationally Relevant Exposure Scenarios.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Bioactive Pyranones Isolated From the Mangrove-Associated Endophytic Fungus Aspergillus sp. H6a.

Chemistry & biodiversity·2026
Same author

Structure-based screening and a conformational biosensor identify a GPR183 inverse agonist and an activation switch.

Nature communications·2026

相关实验视频

Updated: Jun 15, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

深度学习大规模的药物发现和重新定位.

Min Yu1, Weiming Li2, Yunru Yu1

  • 1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

Nature computational science
|August 21, 2024
PubMed
概括
此摘要是机器生成的。

这项研究引入了MitoReID,这是一种深度学习模型,分析线粒体的变化以确定药物作用机制 (MOA). 这种具有成本效益的方法通过剖析细胞表型来加速药物发现和重新利用.

更多相关视频

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

相关实验视频

Last Updated: Jun 15, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

科学领域:

  • 生物化学 生物化学
  • 计算生物学 计算生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 药物发现和重新用途受到昂贵和低通量方法的阻碍,这些方法用于识别作用机制 (MOA).
  • 准确的MOA识别对于有效的药物开发和治疗应用至关重要.

研究的目的:

  • 利用线粒体表型开发一种具有成本效益和高通量方法,用于使用线粒体表型识别MOA.
  • 建立一个深度学习模型来分析时间解析的线粒体图像来预测药物MOA.

主要方法:

  • 创建了一个管道,用于对线粒体形态和膜潜力的时间分辨率成像.
  • 一个数据集由570,096个单细胞图像组成,这些图像来自于用1,068种FDA批准的药物治疗的细胞.
  • 一个深度学习模型,MitoReID,利用重新识别 (ReID) 框架和一个膨胀的3D ResNet骨干,被开发和训练.

主要成果:

  • 在测试组中,MitoReID实现了76.32%的排名-1精度和65.92%的平均精度.
  • 该模型成功地根据线粒体表型识别了六种以前未经训练的药物的MOA.
  • MitoReID确定了循环氧化酶-2抑制作为甲的MOA,该MOA在体外得到了验证.

结论:

  • 开发的方法为MOA识别提供了一个自动化和具有成本效益的替代方案.
  • 这种基于线粒体表型的策略可以显著加速大规模的药物发现和重定向努力.
  • 这些发现突显了深度学习在分析细胞成像数据以获取生物见解方面的潜力.